-
1
-
-
0035051804
-
Mutational evidence for an internal fusion peptide in flavivirus envelope protein E
-
Allison S.L., Schalich J., Stiasny K., Mandl C.W., Heinz F.X. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J. Virol. 75:2001;4268-4275.
-
(2001)
J. Virol.
, vol.75
, pp. 4268-4275
-
-
Allison, S.L.1
Schalich, J.2
Stiasny, K.3
Mandl, C.W.4
Heinz, F.X.5
-
2
-
-
0025116324
-
Flavivirus genome organization, expression, and replication
-
Chambers T.J., Hahn C.S., Galler R., Rice C.M. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 44:1990;649-688.
-
(1990)
Annu. Rev. Microbiol.
, vol.44
, pp. 649-688
-
-
Chambers, T.J.1
Hahn, C.S.2
Galler, R.3
Rice, C.M.4
-
3
-
-
0000445568
-
Molecular biology of dengue viruses
-
D.J. Gubler, & G. Kuno. New York, NY: CAB International
-
Chang G.J. Molecular biology of dengue viruses. Gubler D.J., Kuno G. Dengue and Dengue Hemorrhagic Fever. 1997;175-198 CAB International, New York, NY. Crill W.D., Roehrig J.T. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 75:2001;7769-7773.
-
(1997)
Dengue and Dengue Hemorrhagic Fever
, pp. 175-198
-
-
Chang, G.J.1
-
4
-
-
0034899311
-
Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells
-
Crill W.D., Roehrig J.T. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 75:2001;7769-7773. Delenda C., Staropoli I., Frenkiel M.P., Cabanie L., Deubel V. Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in mice. J. Gen. Virol. 75:1994;1569-1578.
-
(2001)
J. Virol.
, vol.75
, pp. 7769-7773
-
-
Crill, W.D.1
Roehrig, J.T.2
-
5
-
-
0028302115
-
Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: Processing in insect cells and immunogenic properties in mice
-
Delenda C., Staropoli I., Frenkiel M.P., Cabanie L., Deubel V. Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in mice. J. Gen. Virol. 75:1994;1569-1578.
-
(1994)
J. Gen. Virol.
, vol.75
, pp. 1569-1578
-
-
Delenda, C.1
Staropoli, I.2
Frenkiel, M.P.3
Cabanie, L.4
Deubel, V.5
-
6
-
-
0003075995
-
Clinical spectrum of dengue infection
-
D.J. Gubler, & G. Kuno. New York, NY: CAB International
-
George R., Lum L.C.S. Clinical spectrum of dengue infection. Gubler D.J., Kuno G. Dengue and Dengue Hemorrhagic Fever. 1997;23-44 CAB International, New York, NY.
-
(1997)
Dengue and Dengue Hemorrhagic Fever
, pp. 23-44
-
-
George, R.1
Lum, L.C.S.2
-
7
-
-
0002540391
-
Dengue and dengue hemorrhagic fever: Its history and resurgence as a global public health problem
-
D.J. Gubler. New York, NY: CAB International
-
Gubler D.J. Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem. Gubler D.J. Dengue and Dengue Hemorrhagic Fever. 1997;1-22 CAB International, New York, NY.
-
(1997)
Dengue and Dengue Hemorrhagic Fever
, pp. 1-22
-
-
Gubler, D.J.1
-
8
-
-
0034623662
-
Recombinant plasmid expressing a truncated dengue-2 virus E protein without co-expression of prM protein induces partial protection in mice
-
Jimenez R.O., da Fonseca B.A.L. Recombinant plasmid expressing a truncated dengue-2 virus E protein without co-expression of prM protein induces partial protection in mice. Vaccine. 19:2001;648-654.
-
(2001)
Vaccine
, vol.19
, pp. 648-654
-
-
Jimenez, R.O.1
Da Fonseca, B.A.L.2
-
9
-
-
0034702096
-
Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice
-
Kelly E.P., Greene J.J., King A.D., Innis B.L. Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice. Vaccine. 18:2000;2549-2559. Lee E., Lobigs M. Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry. J. Virol. 74:2000;8867-8875.
-
(2000)
Vaccine
, vol.18
, pp. 2549-2559
-
-
Kelly, E.P.1
Greene, J.J.2
King, A.D.3
Innis, B.L.4
-
10
-
-
0033804366
-
Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry
-
Lee E., Lobigs M. Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry. J. Virol. 74:2000;8867-8875.
-
(2000)
J. Virol.
, vol.74
, pp. 8867-8875
-
-
Lee, E.1
Lobigs, M.2
-
11
-
-
0033982257
-
Perspectives for the treatment of infections with Flaviviridae
-
table
-
Leyssen P., De Clercq E., Neyts J. Perspectives for the treatment of infections with Flaviviridae. Clin. Microbiol. Rev. 13:2000;67-82. table.
-
(2000)
Clin. Microbiol. Rev.
, vol.13
, pp. 67-82
-
-
Leyssen, P.1
De Clercq, E.2
Neyts, J.3
-
12
-
-
0025031982
-
The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherichia coli
-
Mason P.W., Zugel M.U., Semproni A.R., Fournier M.J., Mason T.L. The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherichia coli. J. Gen. Virol. 71:1990;2107-2114.
-
(1990)
J. Gen. Virol.
, vol.71
, pp. 2107-2114
-
-
Mason, P.W.1
Zugel, M.U.2
Semproni, A.R.3
Fournier, M.J.4
Mason, T.L.5
-
13
-
-
0037495036
-
A ligand-binding pocket in the dengue virus envelope glycoprotein
-
Modis Y., Ogata S., Clements D., Harrison S.C. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. USA. 100:2003;6986-6991. Monath T.P., Henize F.X. Flaviviruses. third ed. Fields B.N., Knipe D.M., Howley P.M. Fields Virology. vol. 1:1996;961-1034 Lipponcott-Raven Publishers, Philadelphia, PA.
-
(2003)
Proc. Natl. Acad. Sci. USA
, vol.100
, pp. 6986-6991
-
-
Modis, Y.1
Ogata, S.2
Clements, D.3
Harrison, S.C.4
-
14
-
-
0001925194
-
Flaviviruses
-
third ed. B.N. Fields, D.M. Knipe, Howley P.M. Philadelphia, PA: Lipponcott-Raven Publishers
-
Monath T.P., Henize F.X. Flaviviruses. third ed. Fields B.N., Knipe D.M., Howley P.M. Fields Virology. vol. 1:1996;961-1034 Lipponcott-Raven Publishers, Philadelphia, PA.
-
(1996)
Fields Virology
, vol.1
, pp. 961-1034
-
-
Monath, T.P.1
Henize, F.X.2
-
15
-
-
0029014434
-
The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution
-
Rey F.A., Heinz F.X., Mandl C., Kunz C., Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2. Å resolution Nature. 375:1995;291-298.
-
(1995)
Nature
, vol.375
, pp. 291-298
-
-
Rey, F.A.1
Heinz, F.X.2
Mandl, C.3
Kunz, C.4
Harrison, S.C.5
-
16
-
-
0032486594
-
Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica
-
Roehrig J.T., Bolin R.A., Kelly R.G. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology. 246:1998;317-328.
-
(1998)
Virology
, vol.246
, pp. 317-328
-
-
Roehrig, J.T.1
Bolin, R.A.2
Kelly, R.G.3
-
17
-
-
0343831399
-
Dengue virus envelope glycoprotein can be secreted from insect cells as a fusion with the maltose-binding protein
-
Staropoli I., Clement J.M., Frenkiel M.P., Hofnung M., Deubel V. Dengue virus envelope glycoprotein can be secreted from insect cells as a fusion with the maltose-binding protein. J. Virol. Methods. 56:1996;179-189.
-
(1996)
J. Virol. Methods
, vol.56
, pp. 179-189
-
-
Staropoli, I.1
Clement, J.M.2
Frenkiel, M.P.3
Hofnung, M.4
Deubel, V.5
-
18
-
-
0030846892
-
Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice
-
Staropoli I., Frenkiel M.P., Megret F., Deubel V. Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice. Vaccine. 15:1997;1946-1954. Sugrue R.J., Cui T., Xu Q., Fu J., Chan Y.C. The production of recombinant dengue virus E protein using Escherichia coli and Pichia pastoris. J. Virol. Methods. 69:1997;159-169.
-
(1997)
Vaccine
, vol.15
, pp. 1946-1954
-
-
Staropoli, I.1
Frenkiel, M.P.2
Megret, F.3
Deubel, V.4
-
19
-
-
0031471296
-
The production of recombinant dengue virus E protein using Escherichia coli and Pichia pastoris
-
Sugrue R.J., Cui T., Xu Q., Fu J., Chan Y.C. The production of recombinant dengue virus E protein using Escherichia coli and Pichia pastoris. J. Virol. Methods. 69:1997;159-169.
-
(1997)
J. Virol. Methods
, vol.69
, pp. 159-169
-
-
Sugrue, R.J.1
Cui, T.2
Xu, Q.3
Fu, J.4
Chan, Y.C.5
-
20
-
-
0034909177
-
Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: Insight into the neutralization mechanism
-
Thullier P., Demangel C., Bedouelle H., Megret F., Jouan A., Deubel V.et al. Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism. J. Gen. Virol. 82:2001;1885-1892.
-
(2001)
J. Gen. Virol.
, vol.82
, pp. 1885-1892
-
-
Thullier, P.1
Demangel, C.2
Bedouelle, H.3
Megret, F.4
Jouan, A.5
Deubel, V.6
-
21
-
-
0033007152
-
A recombinant Fab neutralizes dengue virus in vitro
-
Thullier P., Lafaye P., Megret F., Deubel V., Jouan A., Mazie J.C. A recombinant Fab neutralizes dengue virus in vitro. J. Biotechnol. 69:1999;183-190.
-
(1999)
J. Biotechnol.
, vol.69
, pp. 183-190
-
-
Thullier, P.1
Lafaye, P.2
Megret, F.3
Deubel, V.4
Jouan, A.5
Mazie, J.C.6
-
22
-
-
0037377629
-
Secreted expression of dengue virus type 2 full-length envelope glycoprotein in Pichia pastoris
-
Wei H.Y., Jiang L.F., Xue Y.H., Fang D.Y., Guo H.Y. Secreted expression of dengue virus type 2 full-length envelope glycoprotein in Pichia pastoris. J. Virol. Methods. 109:2003;17-23.
-
(2003)
J. Virol. Methods
, vol.109
, pp. 17-23
-
-
Wei, H.Y.1
Jiang, L.F.2
Xue, Y.H.3
Fang, D.Y.4
Guo, H.Y.5
|